Moringa Sponsor, LP - 14 May 2026 SCHEDULE 13D/A Report for Silexion Therapeutics Corp Ordinary Shares, par value $0.0135 per share (SLXN)

Filing manager: Moringa Sponsor, LP
Reporting owner: Moringa Sponsor, LP
Security: Silexion Therapeutics Corp Ordinary Shares, par value $0.0135 per share
Beneficially owned shares: 1,382,346 shares
Large-stake signal: Form
SCHEDULE 13D/A
Active or control-oriented beneficial ownership filing.
Ownership
33%
Beneficial ownership of this reported class.
Shares
1,382,346 shares
Shares beneficially owned as disclosed.
Event date
14 May 2026
Date tied to the ownership event or amendment.
Accepted by SEC
29 May 2026
EDGAR acceptance date.
How to read this large-stake filing
Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
Compare this filing with the holder history and issuer page before treating the percentage as a current position.
Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Class ownership: 33%
Symbol: SLXN
Shares outstanding: 4,190,197 shares
SEC form: SCHEDULE 13D/A
Accepted by SEC: 29 May 2026, 16:00:17 UTC
Event date: 14 May 2026
Prior SEC filing: 23 Sep 2025
Source filing: View source filing

Key filing fact

Moringa Sponsor, LP disclosed 33% ownership in Silexion Therapeutics Corp Ordinary Shares, par value $0.0135 per share (SLXN) on 14 May 2026.

Key facts

Moringa Sponsor, LP filed SCHEDULE 13D/A for Silexion Therapeutics Corp Ordinary Shares, par value $0.0135 per share (SLXN).
Disclosed ownership: 33%.
Date of event: 14 May 2026.

This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Reporting persons

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name	Ownership	Shares owned	Sole voting power	Shared voting power	Signature	Title	CIK
Moringa Sponsor, LP	33%	1,382,346	1,382,346	0	/s/ Ilan Levin	Ilan Levin / Director of Moringa Partners Ltd., the sole General Partner of Moringa Sponsor, LP	0001849192
Moringa Partners Ltd	33%	1,382,346	0	1,382,346	/s/ Ilan Levin	Ilan Levin / Director
Ilan Levin	33%	1,382,346	0	1,382,346	/s/ Ilan Levin	Ilan Levin	0001849189

CIK / CUSIP context first

Broader feeds